| Literature DB >> 20548880 |
Jong Won Seo1, Hyun Ho Son, Joon Hee Choi, Sook Kyung Lee.
Abstract
Propylthiouracil is a common medication used in patients with hyperthyroidism; it can cause perinuclear antineutrophil cytoplasmic antibodies (p-ANCA) in some patients with Graves' disease. This antibody has been associated with various forms of vasculitis and neutrophilic dermatosis. Herein, we report a patient who presented with cutaneous manifestations of pyoderma gangrenosum with simultaneous development of p-ANCAs during PTU therapy for Graves' disease.Entities:
Keywords: Propylthiouracil; Pyoderma gangrenosum; p-ANCA
Year: 2010 PMID: 20548880 PMCID: PMC2883396 DOI: 10.5021/ad.2010.22.1.48
Source DB: PubMed Journal: Ann Dermatol ISSN: 1013-9087 Impact factor: 1.444